Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
07Jan2026
  • Home
  • About
  • News
  • Subscribe
07Jan2026
Cost Curve NewsCost Curve News
Cost Curve News

A New Tracker for Watching Meds That Might See Prices Slashed

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 weeks ago
Keep Reading
Cost Curve News

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 weeks ago
Keep Reading
Cost Curve News

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 weeks ago
Keep Reading
Cost Curve News

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 month ago
Keep Reading
Cost Curve News

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 month ago
Keep Reading
Cost Curve News

The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 month ago
Keep Reading
Cost Curve News

The U.K. Will Make Efforts to Boost Drug Prices in Return for the Elimination of U.S. Tariffs

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 month ago
Keep Reading
Cost Curve News

The Search for Clarity on the Differences Between IRA and MFN Prices for Ozempic and Wegovy

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 month ago
Keep Reading
Cost Curve News

Medicare Negotiated Prices Are Out for 15 More Drugs. Here’s What We Know

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 month ago
Keep Reading
Cost Curve News

Today Is Mostly a Day for Waiting

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 month ago
Keep Reading
123

Latest Posts

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

January 6, 2026

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

January 5, 2026

Happy Festivus! Cost Curve Readers Have Some Grievances They’d Like to Air.

December 23, 2025

Christmas Comes Early for the Wonks, With CMS Demonstrations and MFN Announcements

December 22, 2025

The Number of Companies Set to Make MFN Announcements Today Is Up to At Least Six

December 19, 2025

Popular

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

Happy Festivus! Cost Curve Readers Have Some Grievances They’d Like to Air.

Christmas Comes Early for the Wonks, With CMS Demonstrations and MFN Announcements

The Number of Companies Set to Make MFN Announcements Today Is Up to At Least Six

Novartis, Roche, AbbVie Reportedly on Deck for White House MFN Announcements Tomorrow

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (3,048)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,219)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,997)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,811)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,801)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

January 6, 2026

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

January 5, 2026

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2026 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe